Funded Tech Companies
Alios BioPharma
Looking for the company that acquired Alios BioPharma? Alios BioPharma was acquired by Johnson & Johnson.
Company Overview
Company Name
Alios BioPharma
Company Status
Acquired or Merged
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
260 East Grand Ave. 2nd Floor
South San Francisco, CA 94080
USA
South San Francisco, CA 94080
USA
Phone
Website
Email Address
Company Background Information
Overview
Alios is discovering and developing novel therapeutic agents based on three platform technologies including: small molecule activators of innate immunity antiviral pathways (RNase L activation), phosphate protected nucleotide prodrug chemistry, and glycoprotein-engineering of interferons (Glycoferona).
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
10/1/2014
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Lawrence Blatt
Chief Scientific Officer
Leonid Beigelman
Founder
John Donovan
Company Investors
- SR One Capital Management (Jens Eckstein)
- Roche Venture Fund (Carole Nuechterlein)
- Novartis Venture Fund (Campbell Murray)
- Novo Ventures (Jack Nielsen)
- SR One Capital Management (Kent Gossett)
- GlaxoSmithKline
- Novartis BioVenture Fund
Browse more funded tech companies:
Share this article
About Our VC & M&A Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs